When evaluating research compounds for endocrine and metabolic signaling studies, understanding distinct biochemical targets is critical for sound experimental design. This technical overview provides a head-to-head comparison of Kisspeptin-10 and 5-Amino-1MQ, detailing their divergence in molecular structure, receptor interaction, and preclinical assay utility. All data presented are restricted to in vitro and preclinical animal model contexts for qualified research entities.
When evaluating research compounds for endocrine and metabolic signaling studies, understanding distinct biochemical targets is critical for sound experimental design. This technical overview provides a head-to-head comparison of Kisspeptin-10 and 5-Amino-1MQ, detailing their divergence in molecular structure, receptor interaction, and preclinical assay utility. All data presented are restricted to in vitro and preclinical animal model contexts for qualified research entities.
Kisspeptin-10 and 5-Amino-1MQ represent entirely different biochemical classes designed for distinct physiological targets in preclinical research. Kisspeptin-10 is a endogenous decapeptide that acts as a potent KISS1 receptor agonist, driving neuroendocrine gonadotropin-releasing hormone (GnRH) signaling. Conversely, 5-Amino-1MQ is a small-molecule membrane-permeable selective inhibitor of nicotinamide N-methyltransferase (NNMT), studied for raising intracellular NAD+ levels, improving mitochondrial output, and supporting fat-metabolism research. While Kisspeptin-10 modulates reproductive axis signaling, 5-Amino-1MQ targets cellular energy kinetics and methyl group flux.
To assist laboratory personnel in protocol development, the table below outlines the core chemical and biological parameters differentiating these two research compounds. Detailed batch purity metrics can be reviewed on our public COA repository.
| Criteria | Kisspeptin-10 | 5-Amino-1MQ | | :--- | :--- | :--- | | **Molecular Class** | Endogenous Peptide (Decapeptide) | Small-Molecule Quinoline Derivative | | **Primary Biochemical Target** | KISS1 Receptor (GPR54 Agonist) | Nicotinamide N-Methyltransferase (NNMT Inhibitor) | | **Primary Mechanism** | Stimulation of GnRH release & HPG axis modulation | Prevention of N-methylnicotinamide formation, boosting intracellular NAD+ | | **Reported In Vivo Half-Life** | ~2–10 minutes (Rapid enzymatic degradation) | ~2–5 hours (Varies by mammalian model and delivery vehicle) | | **Solubility Profile** | Water-soluble; reconstitution in sterile bacteriostatic water/PBS | Hydrophobic / Moderately lipophilic; soluble in DMSO / ethanol blends | | **Typical Preclinical Model** | Rodent neuroendocrine, reproductive biology, & LH/FSH pulse assays | Murine high-fat diet models, metabolic cage studies, & myoblast differentiation | | **Standard Vial Configuration** | Lyophilized powder (5 mg / 10 mg vials) | Pure solid powder (10 mg / 50 mg research vials) |
Kisspeptin-10 is the shortest fully functional cleavage fragment of the endogenous KISS1 gene product. It possesses high binding affinity for the KISS1 receptor (KISS1R, formerly GPR54), a G-protein-coupled receptor predominantly localized in hypothalamic arcuate and anteroventral periventricular nuclei. Upon binding, Kisspeptin-10 triggers a Gq/11-mediated intracellular cascade, stimulating phospholipase C (PLC) and mobilizing intracellular calcium. This activation drives pulsed exocytosis of gonadotropin-releasing hormone (GnRH) into the hypophyseal portal system.
In preclinical animal models, Kisspeptin-10 administration is utilized to investigate downstream luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion patterns. Researchers frequently employ Kisspeptin-10 to map the Central Nervous System (CNS) control of puberty, feedback regulation by gonadal steroids, and central reproductive dysfunction. Due to its peptide backbone, it undergoes rapid cleavage by endopeptidases in plasma, making it an excellent tool for studying acute pulse kinetics rather than sustained long-term signal exposure.
In addition to its central endocrine role, in vitro assays have identified KISS1R expression in peripheral tissues, including vascular endothelial cells and the placenta. Preclinical literature suggests that Kisspeptin-10 signaling may influence cell migration, angiogenesis, and extravasation, allowing researchers to explore its potential outside purely neuroendocrine frameworks.
In contrast to receptor-activating peptides, 5-Amino-1MQ is a targeted small-molecule enzyme inhibitor that directly targets nicotinamide N-methyltransferase (NNMT). NNMT is a cytosolic enzyme responsible for methylating nicotinamide (NAM) using S-adenosylmethionine (SAM) as a methyl donor. By converting NAM into 1-methylnicotinamide (MNA), NNMT effectively removes NAM from the salvage pathway, preventing its conversion back into nicotinamide adenine dinucleotide (NAD+). Elevated NNMT activity is widely documented in high-fat-diet rodent tissues, senescent cell populations, and dysfunctional adipocytes.
5-Amino-1MQ functions as a competitive inhibitor of NNMT. By blocking this enzymatic clearance pathway, 5-Amino-1MQ preserves intracellular NAM concentrations and drives NAD+ synthesis via the salvage enzyme NAMPT. Consequently, preclinical literature shows that treatment with 5-Amino-1MQ increases intracellular NAD+ levels, which in turn enhances sirtuin-1 (SIRT1) activity and AMP-activated protein kinase (AMPK) phosphorylation.
Grounding facts confirm that 5-Amino-1MQ is actively studied for raising NAD+ levels, improving mitochondrial output, and supporting fat-metabolism research. In diet-induced obesity rodent models, NNMT inhibition via 5-Amino-1MQ has been correlated with increased basal metabolic rate, reduced adipocyte cell volume, elevated oxygen consumption, and enhanced mitochondrial biogenesis in skeletal muscle tissue without altering daily calorie consumption.
A critical distinction between these two compounds lies in their half-life and metabolic disposition within experimental systems. Kisspeptin-10 is highly vulnerable to systemic peptidases, specifically neutral endopeptidase (NEP) and prolyl endopeptidase. In vivo rodent plasma assays report a systemic half-life ranging from 2 to 10 minutes following intravenous bolus administration. This brief half-life necessitates timed sampling protocols or continuous infusion setups when tracking downstream pituitary hormone release.
5-Amino-1MQ exhibits a significantly longer biological half-life typical of lipophilic small molecules. In rodent pharmacokinetic models, oral or parenteral administration demonstrates systemic bioavailability with plasma clearance half-lives extending between 2 and 5 hours. Because 5-Amino-1MQ operates by inhibiting intracellular enzyme kinetics rather than transiently depolarizing membrane receptors, its downstream metabolic effects—such as elevated NAD+ pools and activated SIRT1 signaling—can persist for hours after plasma clearance.
Researchers evaluating structural stability should note that while peptide stability in liquid phase requires strict temperature management, small molecules like 5-Amino-1MQ are less prone to proteolytic cleavage but require careful solvent selection to prevent precipitation during in vitro cell culture dosing.
When designing comprehensive comparative studies, laboratory investigators often cross-reference Kisspeptin-10 and 5-Amino-1MQ with other foundational research peptides and metabolic tools across our all-peptides catalog. To establish robust control groups, researchers should evaluate related peptides within each functional cluster.
In neuroendocrine research setups, Kisspeptin-10 performance is frequently compared against GnRH analogs like Gonadorelin or long-acting agonists such as Triptorelin to dissect receptor desensitization mechanisms versus pulsatile activation patterns. In mitochondrial and metabolic research, 5-Amino-1MQ is often studied alongside mitochondrial-derived peptides like MOTS-c or PPAR-delta agonists to measure synergistic improvements in cellular respiration, oxygen consumption rates (OCR), and fatty acid oxidation assays.
By utilizing structured panel testing across these distinct compound classes, laboratories can isolate whether observed physiological changes stem from direct central axis stimulation, peripheral enzyme inhibition, or primary mitochondrial gene transcription.
Determining whether to deploy `kisspeptin-10 vs 5-amino-1mq` in a given study depends entirely on the primary endpoint defined in the research protocol. The two compounds are non-overlapping in target tissues and downstream biochemical pathways.
Choose Kisspeptin-10 if your research aims to evaluate: - Neuroendocrine control of the Hypothalamic-Pituitary-Gonadal (HPG) axis. - Acute pulse frequency and amplitude of GnRH, LH, or FSH secretion in animal models. - Feedback inhibition pathways involved in reproductive biology or pubertal timing. - Peripheral KISS1R expression in vascular or tumor cell migration models.
Choose 5-Amino-1MQ if your research aims to evaluate: - Direct inhibition of NNMT enzyme activity in adipocytes, hepatocytes, or myoblasts. - Cellular NAD+ restoration pathways, sirtuin activation, and SAM/SAH methyl donor ratios. - Mitochondrial respiration, basal metabolic rate, and fat oxidation rates in high-fat diet rodent models. - Muscle fiber hypertrophy and stem cell differentiation capacity during metabolic stress.
For complex multi-pathway investigations, some laboratories study both compounds in parallel cohorts to contrast central neuroendocrine modulation against direct peripheral tissue energy regulation. Full documentation on compound specifications and handling can be accessed via our central research hub.
Proper reconstitution and vehicle preparation are mandatory to preserve structural integrity and prevent concentration errors during assay execution. Because these compounds belong to different chemical classes, their handling protocols differ fundamentally.
Kisspeptin-10 is provided as a lyophilized hydrophilic peptide powder. It should be reconstituted using sterile bacteriostatic water or phosphate-buffered saline (PBS, pH 7.4). Rapid dissolving occurs upon mild swirling; avoid vigorous vortexing to prevent peptide denaturation. For exact volume calculations, researchers should utilize the PX1 reconstitution-calculator. Stock solutions should be aliquoted into single-use polypropylene tubes and stored at -80°C to minimize freeze-thaw degradation.
5-Amino-1MQ is supplied as a dry synthetic small molecule powder with low aqueous solubility in pure water. Stock solutions are typically prepared using dimethyl sulfoxide (DMSO) or 100% anhydrous ethanol before dilution into aqueous cell culture media or vehicle buffers. Care must be taken to ensure final DMSO concentrations remain below toxic thresholds (<0.1% v/v) in cell culture assays. Dry powder vials should be stored desiccated at -20°C away from direct light exposure.
In modern preclinical research, batch-to-batch consistency and absolute chemical purity are non-negotiable requirements for reproducible data. PX1 Research manufactures and distributes premium-grade research compounds strictly for in vitro and laboratory evaluation.
Every production lot of Kisspeptin-10 and 5-Amino-1MQ undergoes rigorous analytical testing in ISO 17025 accredited testing facilities. Our quality control protocols include: - High-Performance Liquid Chromatography (HPLC) to confirm peptide purity ≥98%. - Mass Spectrometry (MS) verification to confirm exact identity and molecular mass. - Bacterial Endotoxin Testing (Chromogenic LAL assay) ensuring levels remain well within strict laboratory thresholds. - Heavy metal and residual solvent screening.
All products are manufactured in GMP-compliant facilities located within the USA, with inventory stored and dispatched directly from our California and Arizona logistics hubs. Verified academic laboratories, biotechnology firms, and institutional research accounts can explore custom batch ordering and volume quotes via our dedicated wholesale program.
What is the primary difference in mechanism between Kisspeptin-10 and 5-Amino-1MQ?
Kisspeptin-10 is a decapeptide agonist that binds to the KISS1 receptor (GPR54) to stimulate GnRH and downstream gonadotropin release in the HPG axis. 5-Amino-1MQ is a small-molecule selective inhibitor of the enzyme NNMT, studied for raising intracellular NAD+ levels, enhancing mitochondrial output, and supporting fat-metabolism research.
Can Kisspeptin-10 and 5-Amino-1MQ be reconstituted using the same solvent?
No. Kisspeptin-10 is a hydrophilic peptide best reconstituted in sterile bacteriostatic water or PBS. 5-Amino-1MQ is a small molecule with hydrophobic characteristics that requires initial dissolution in organic solvents like DMSO or ethanol before dilution into working buffers.
What is the reported in vivo half-life of Kisspeptin-10 in preclinical models?
In vivo rodent and mammalian models show that Kisspeptin-10 has a brief plasma half-life of approximately 2 to 10 minutes due to rapid cleavage by endogenous endopeptidases.
How does 5-Amino-1MQ impact intracellular NAD+ levels?
5-Amino-1MQ inhibits nicotinamide N-methyltransferase (NNMT), preventing the conversion of nicotinamide (NAM) into 1-methylnicotinamide (MNA). By blocking this clearance route, NAM remains available for the NAD+ salvage pathway, resulting in elevated intracellular NAD+ concentrations.
Where are PX1 Research compounds manufactured and tested?
All PX1 Research compounds are manufactured in USA-based, GMP-compliant facilities. Every lot undergoes independent ISO 17025 third-party laboratory verification, including HPLC purity testing, MS identity confirmation, and chromogenic endotoxin screening.
Are Kisspeptin-10 or 5-Amino-1MQ approved for human consumption or therapeutic use?
No. Both compounds are strictly sold as chemical reagents for laboratory research use only. They are not intended, formulated, or cleared for human or veterinary use, clinical trials, or therapeutic applications.
How should reconstituted Kisspeptin-10 stock solutions be stored for long-term stability?
Once reconstituted, Kisspeptin-10 stock solutions should be divided into single-use aliquots to prevent repeat freeze-thaw cycles and stored in sterile polypropylene tubes at -80°C for optimal peptide stability.
What analytical documents are included with orders from PX1 Research?
Every lot is accompanied by a batch-specific Certificate of Analysis (COA) detailing HPLC chromatograms, mass spectrometry profiles, purity percentages, and endotoxin assay results, which can be verified online prior to experimental use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.